Jean Lang

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

Arunee Sabchareon, Derek Wallace, Chukiat Sirivichayakul et al. · The Lancet · 2012 · 805 citations

Vaccination, Vaccine Safety, Vaccinology +8

Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres

Y Mouton, S. Alfandari, M. Valette et al. · AIDS · 1997 · 363 citations

Safety and Efficacy of Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine Formulations in Nonhuman Primates

Farshad Guirakhoo, Z. Zhang, Gene Myers et al. · Journal of Virology · 2004 · 252 citations · Full text

Synthetic Virology, Immunology, Den Virus Serotypes +16

Treatment of Severe Colchicine Overdose with Colchicine-Specific Fab Fragments

Frédéric J. Baud, A. Sabouraud, Éric Vicaut et al. · New England Journal of Medicine · 1995 · 233 citations · Full text

Live Attenuated Chimeric Yellow Fever Dengue Type 2 (ChimeriVax™-DEN2) Vaccine: Phase I Clinical Trial for Safety and Immunogenicity: Effect of Yellow Fever Pre-immunity in Induction of Cross Neutralizing Antibody Responses to All

Farshad Guirakhoo, Scott Kitchener, Dennis Morrison et al. · Human Vaccines · 2006 · 191 citations · Full text